Journal
Neuro-Oncology Advances
Publication Date
1-1-2022
Volume
4
Issue
1
First Page
vdab186
Document Type
Open Access Publication
DOI
10.1093/noajnl/vdab186
Rights and Permissions
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, Merit E Cudkowicz, Robin A Conwit, Anna L Gudjonsdottir, Dixie J Ecklund, Janel K Fedler, Tina M Neill-Hudson, Louis B Nabors, Melanie Benge, James R Hackney, Marianne Chase, Timothy P Leonard, Toral Patel, Howard Colman, Macarena de la Fuente, Rekha Chaudhary, Karen Marder, Teri Kreisl, Nimish Mohile, Milan G Chheda, Katharine McNeill, Priya Kumthekar, Aclan Dogan, Jan Drappatz, Vinay Puduvalli, Agnes Kowalska, Jerome Graber, Elizabeth Gerstner, Stephen Clark, Michael Salacz, James Markert, Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdab186, https://doi.org/10.1093/noajnl/vdab186. © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Griguer, Corinne E; Chheda, Milan G; and et al., "Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial." Neuro-Oncology Advances. 4, 1. vdab186 (2022).
https://digitalcommons.wustl.edu/oa_4/738
Additional Links
Supplemental material is available for this article at publisher site.
